Phathom Pharmaceuticals, Inc. Common Stock PHAT
$5.94
+3.48%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-26 | View → |
| 8-K | 8-K | 2026-10-23 | View → |
| 4 | 4 | 2026-10-08 | View → |
| 8-K | 8-K | 2026-09-29 | View → |
| 4 | 4 | 2026-09-08 | View → |
| 10-Q | 10-Q | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | 4 | 2026-07-16 | View → |
| 8-K | 8-K | 2026-06-23 | View → |
| 4 | 4 | 2026-05-27 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 4 | 4 | 2026-05-21 | View → |
| 8-K | 8-K | 2026-05-21 | View → |
| 10-Q | 10-Q | 2026-04-30 | View → |
| 8-K | 8-K | 2026-04-30 | View → |
| DEF 14A | DEF 14A | 2026-04-07 | View → |
| 4 | 4 | 2026-03-11 | View → |
| 4 | 4 | 2026-03-03 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | 4 | 2026-02-12 | View → |
| 4 | 4 | 2026-02-12 | View → |
| 4 | 4 | 2026-01-27 | View → |
| 4 | 4 | 2026-01-23 | View → |
| 4 | 4 | 2026-01-15 | View → |
| 8-K | 8-K | 2026-01-08 | View → |
| 424B5 | 424B5 | 2026-01-08 | View → |
| 424B5 | 424B5 | 2026-01-07 | View → |
| 8-K | 8-K | 2026-01-07 | View → |
| 4 | 4 | 2026-01-02 | View → |
| 4 | 4 | 2026-01-02 | View → |
| 4 | 4 | 2026-01-02 | View → |
| 4 | 4 | 2025-12-23 | View → |
| 4 | 4 | 2025-12-19 | View → |
| 4 | 4 | 2025-12-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $5.94
- Market Cap
- $464.37 million
- 52-Week Range
- $5.01 – $18.31
- Average Volume
- 1.47 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.